You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.